Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase inhibitor p16 is a candidate tumour-suppressor protein that maps to a genomic locus strongly associated with familial melanoma and other tumour types. Screening of primary tumours and linkage analysis of familial melanoma pedigrees have identified many potential mutations in p16, but the functional significance of these sequence variants has remained unclear. We report here that p16 can act as a potent and specific inhibitor of progression through the G1 phase of the cell cycle, and we demonstrate that several tumour-derived alleles of p16 encode functionally compromised proteins. The ability of p16 to arrest cell-cycle progression generally correlates with inhibition of cyclin D1/Cdk4 kinase activity in vitro, with two exceptions among the alleles tested. In vivo, the presence of functional retinoblastoma protein appears to be necessary but may not be sufficient to confer full sensitivity to p16-mediated growth arrest. Our results provide support for the notion that p16 is an important cell-cycle regulator whose inactivation contributes to the outgrowth of human tumours.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, cells lacking functional RB were resistant to p16INK4a-mediated cell cycle arrest, implying that the ability of CDK4 (and later, CDK6) to drive G1 phase progression required RB (33-35) and predicting that chemical CDK4/6 inhibitors would show efficacy only if RB were functionally intact.”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [35]
Citations
Cites
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,136
Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control
van den Heuvel, S., & Harlow, E. (1993) · Science · doi:10.1126/science.8266103 · Cited by 1,092
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Research works printed but not linked: 2
- Mori, T. et al. Canc. Res. 54, 3396–3397 (1994).
- Otterson, G. A., Kratzke, R. A., Coxon, A., Kim, Y. W. & Kaye, F. J. Oncogene 9, 3375–3378 (1994).
Cited by
Items 201–300 of 513
Ruas, M., Brookes, S., McDonald, N. Q., & Peters, G. G. (1999) · Oncogene · doi:10.1038/sj.onc.1202918 · Cited by 81
Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity
Lilischkis, R., Šarčević, B., Kennedy, C. J., Warlters, A., & Sutherland, R. L. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960410)66:2<249::aid-ijc19>3.0.co;2-7 · Cited by 81
Gabrielli, B. G., Šarčević, B., Sinnamon, J., Walker, G. J., Castellano, M., Wang, X., & Ellem, K. A. O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13961 · Cited by 79
Knudsen, K. E., Fribourg, A. F., Strobeck, M. W., Blanchard, J.-M., & Knudsen, E. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27632 · Cited by 73
Nasu, K., Kohsaka, H., Nonomura, Y., Terada, Y., Ito, H., Hirokawa, K., & Miyasaka, N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7246 · Cited by 75
Lukas, J., Sørensen, C. S., Lukas, C., Santoni‐Rugiu, E., & Bártek, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202777 · Cited by 79
Analysis of Cell-Cycle Profiles in Transfected Cells Using a Membrane-Targeted GFP
Jiang, W. B., & Hunter, T. R. (1998) · BioTechniques · doi:10.2144/98243bm03 · Cited by 73
Amara, K., Trimèche, M., Ziadi, S., Laatiri, A., Hachana, M., & Korbi, S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn374 · Cited by 79
CDKN2a/p16INK4a Mutations and Lack of p19ARF Involvement in Familial Melanoma Kindreds
Fargnoli, M. C., Chimenti, S., Peris, K., Keller, G., Soyer, H. P., Pozzo, V. D., & Höfler, H. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00412.x · Cited by 80
Tevelev, A., Byeon, I. L., Selby, T. L., Ericson, K. L., Kim, H. J., Kraynov, V. S., & Tsai, M. (1996) · Biochemistry · doi:10.1021/bi960211+ · Cited by 85
Smad3 phosphorylation by cyclin-dependent kinases
LIU, F. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.010 · Cited by 71
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling
Vergara, I. A., Mintoff, C., Sandhu, S. K., McIntosh, L., Young, R. J., Wong, S. Q., Colebatch, A. J., Cameron, D., Lai-Kwon, J. E., Wolfe, R. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21576-8 · Cited by 72
Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress
Yin, Y., Solomon, G., Deng, C., & Barrett, J. C. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199901)24:1<15::aid-mc3>3.0.co;2-y · Cited by 71
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10<2099::aid-cncr8>3.0.co;2-3 · Cited by 2,101
Chen, T.-T., & Wang, J. Y. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5571-5580.2000 · Cited by 71
Cyclin D- and E-Dependent Kinases and the p57KIP2 Inhibitor: Cooperative Interactions In Vivo
Lahoz, E. G., Liégeois, N. J., Zhang, P., Engelman, J. A., Horner, J. W., Silverman, A., Burde, R. M., Roussel, M. F., Sherr, C. J., Elledge, S. J., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.353 · Cited by 76
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect
Auroy, S., Avril, M., Chompret, A., Pham, D., Goldstein, A. M., Bianchi‐Scarrà, G., Frébourg, T., Joly, P., Spatz, A., Rubino, C., et al. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1183 · Cited by 72
Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease
Arendt, T. (2001) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(01)00007-7 · Cited by 67
Yildiz-Aktas, I. Z., Usubutün, A., Fırat, P., Ayhan, A., & Küçükali, T. (2007) · Pathology - Research and Practice · doi:10.1016/j.prp.2007.03.010 · Cited by 75
Influence of human papillomavirus and p16INK4a on treatment outcome of patients with anal cancer
Koerber, S. A., Schoneweg, C., Slynko, A., Krug, D. A., Haefner, M. F., Herfarth, K. K., Debus, J., Sterzing, F., Doeberitz, M. V. K., Prigge, E., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.11.013 · Cited by 65
Brown, C. A., Bogers, J., Sahebali, S., Depuydt, C., Prins, F. D., & Malinowski, D. P. (2012) · Journal of Oncology · doi:10.1155/2012/289315 · Cited by 71
Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System
Hallett, S. T., Pastok, M. W., Morgan, R. M. L., Wittner, A., Blundell, K. L. I. M., Felletár, I., Wedge, S. R., Prodromou, C., Noble, M. E. M., Pearl, L. H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.042 · Cited by 67
p16INK4a promoter methylation and protein expression in breast fibroadenoma and carcinoma
Vinci, A. D., Perdelli, L., Banelli, B., Salvi, S., Casciano, I., Gelvi, I., Allemanni, G., Margallo, E., Gatteschi, B., & Romani, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20771 · Cited by 71
p16INK4a expression in actinic keratosis and Bowen's disease
Salama, M. E., Mahmood, M. N., Qureshi, H., Ma, C., Zarbo, R. J., & Ormsby, A. (2003) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2003.05654.x · Cited by 64
Genetic Replacement of Cyclin D1 Function in Mouse Development by Cyclin D2
Carthon, B. C., Neumann, C. A., Das, M., Pawlyk, B. S., Li, T., Geng, Y., & Siciński, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1081-1088.2005 · Cited by 72
Protein dephosphorylation and the intracellular control of the cell number
Berndt, N. (1999) · Frontiers in bioscience · doi:10.2741/berndt · Cited by 70
Defective Folding of Mutant p16INK4 Proteins Encoded by Tumor-derived Alleles
Zhang, B., & Peng, Z.-Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28734 · Cited by 64
Loignon, M., Fetni, R., Gordon, A. J., & Drobetsky, E. A. (1997) · PubMed · Cited by 75
Genetic testing in hereditary melanoma
Tsao, H., & Niendorf, K. B. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.045 · Cited by 73
CDKN2A Germline Mutations in Individuals with Cutaneous Malignant Melanoma
Orlow, I., Begg, C. B., Cotignola, J., Roy, P., Hummer, A., Clas, B. A., Mujumdar, U., Canchola, R., Armstrong, B. K., Kricker, A., et al. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700689 · Cited by 74
Association Between INK4a-ARF and p53 Mutations in Skin Carcinomas of Xeroderma Pigmentosum Patients
Soufir, N., Daya-Grosjean, L., de La Salmonière, P., Moles, J. P., Dubertret, L., Sarasin, A., & Basset-Seguin, N. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1841 · Cited by 73
Wei, X., Shi, J., Lin, Q., Ma, X., Pang, Y., Mao, H., Li, R., Lü, W., Wang, Y., & Liu, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.642229 · Cited by 69
Epigenetics of prostate cancer
Li, L. (2007) · Frontiers in bioscience · doi:10.2741/2320 · Cited by 63
Schnier, J. B., Nishi, K., Goodrich, D. W., & Bradbury, E. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5941 · Cited by 62
Horn, L., Lindner, K., Szepankiewicz, G., Edelmann, J., Hentschel, B., Tannapfel, A., Bilek, K., Liebert, U.-G., Richter, C. E., Einenkel, J., et al. (2006) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000185406.85685.df · Cited by 60
Adamsen, B. L., Kravik, K., Clausen, O. P. F., & Angelis, P. D. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.6.1491 · Cited by 64
Prognostic Significance of Overexpressed p16INK4a in Patients with Cervical Cancer: A Meta-Analysis
Lin, J.-Y., Albers, A. E., Qin, J., & Kaufmann, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106384 · Cited by 66
Genetic predisposition to melanoma
Hawkes, J. E., Truong, A., & Meyer, L. J. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.08.003 · Cited by 70
Priming in the brain, an immunologically privileged organ, elicits anti-tumor immunity
Fathallah‐Shaykh, H. M., Gao, W., Cho, M., & Herrera, M. A. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980119)75:2<217::aid-ijc9>3.0.co;2-x · Cited by 36
Thullberg, M., Bártek, J., & Lukas, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203579 · Cited by 64
Molecular targets of HPV oncoproteins: Potential biomarkers for cervical carcinogenesis
de Freitas, A. C., Coimbra, E. C., & Leitão, M. D. C. G. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.004 · Cited by 69
The Physiology of p16INK4A-Mediated G1 Proliferative Arrest
Shapiro, G. I., Edwards, C. D., & Rollins, B. J. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:33:2:189 · Cited by 63
Torre, G. D., Pasini, B., Frigerio, S., Donghi, R., Rovini, D., Delia, D., Peters, G., Huot, T. J. G., Bianchi‐Scarrà, G., Lantieri, F., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1991 · Cited by 65
Mechanisms of TGF-β-Induced Cell Cycle Arrest
Hocevar, B. A., & Howe, P. H. (1998) · Mineral and Electrolyte Metabolism · doi:10.1159/000057360 · Cited by 62
Reddy, K. B., Krueger, J. S., B. Kondapaka, S., & Diglio, C. A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990719)82:2<268::aid-ijc18>3.0.co;2-4 · Cited by 149
Alevizopoulos, K., Catarin, B., Vlach, J., & Amati, B. B. (1998) · The EMBO Journal · doi:10.1093/emboj/17.20.5987 · Cited by 58
Lewis, J. L., Chinswangwatanakul, W., Zheng, B., Marley, S. B., Nguyen, D. X., Cross, N. C. P., Banerji, L., Glassford, J., Thomas, N. S. B., Goldman, J. M., et al. (2001) · Blood · doi:10.1182/blood.v97.9.2604 · Cited by 53
Biologic and Biochemical Analyses of p16INK4a Mutations From Primary Tumors
Yarbrough, W. G., Buckmire, R. A., Bessho, M., & Liu, E. T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1569 · Cited by 49
Becker, T. M., Rizos, H., Kefford, R. F., & Mann, G. J. (2001) · PubMed · Cited by 54
Inhibition of Proliferation and Apoptosis by the Transcriptional Repressor Mad1
Gehring, S., Rottmann, S., Menkel, A. R., Mertsching, J., Krippner‐Heidenreich, A., & Lüscher, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10413 · Cited by 64
Sarkar, D., & Fisher, P. B. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.003 · Cited by 57
Adachi, M., Roussel, M. F., Havenith, K., & Sherr, C. J. (1997) · Blood · doi:10.1182/blood.v90.1.126 · Cited by 51
Cyclin-Dependent Kinase Inhibitors and Human Cancer
Kamb, A. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_7 · Cited by 57
Methylation of the p16INK4A gene in multiple myeloma
Tasaka, T., Asou, H., Munker, R., Said, J. W., Berenson, J., Vescio, R. A., Nagai, M., Takahara, J., & Koeffler, H. P. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00724.x · Cited by 49
Boquoi, A., Arora, S., Chen, T., Litwin, S., Koh, J., & Enders, G. H. (2015) · Aging Cell · doi:10.1111/acel.12279 · Cited by 49
CDKN2A mutation and deletion status in thin and thick primary melanoma.
Cachia, A. R., Indsto, J. O., McLaren, K. M., Mann, G. J., & Arends, M. J. (2000) · PubMed · Cited by 49
Frost, S. J., Simpson, D. J. W., Clayton, R. N., & Farrell, W. E. (1999) · Molecular Endocrinology · doi:10.1210/me.13.11.1801 · Cited by 52
Lahti, J. M., Li, H., & Kidd, V. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10859 · Cited by 50
Cyclin D3 Regulates Proliferation and Apoptosis of Leukemic T Cell Lines
Boonen, G. J. J. C., van Oirschot, B. A., van Diepen, A., Mackus, W. J. M., Verdonck, L. F., Rijksen, G., & Medema, R. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34676 · Cited by 48
Phosphorylation of p16 Correlates with Cdk4 Association
Gump, J., Stokoe, D., & McCormick, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200622200 · Cited by 47
Budina-Kolomets, A., Hontz, R. D., Pimkina, J., & Murphy, M. E. (2013) · Autophagy · doi:10.4161/auto.25831 · Cited by 46
Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors
Yin, D., Xie, D., Hofmann, W., Miller, C. W., Black, K. L., & Koeffler, H. P. (2002) · Oncogene · doi:10.1038/sj.onc.1206031 · Cited by 49
Melanoma Susceptibility Genes and Risk Assessment
Marzuka-Alcalá, A., Gabree, M., & Tsao, H. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-727-3_20 · Cited by 50
A p18 mutant defective in CDK6 binding in human breast cancer cells.
Lapointe, J., Lachance, Y., Labrie, Y., & Labrie, C. (1996) · PubMed · Cited by 46
Bamberger, A., Sudahl, S., Bamberger, C. M., Schulte, H. M., & Löning, T. (1999) · Placenta · doi:10.1053/plac.1999.0396 · Cited by 46
Genetic Evidence for Functional Dependency of p18Ink4c on Cdk4
Pei, X.-H., Bai, F., Tsutsui, T., Kiyokawa, H., & Xiong, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6653-6664.2004 · Cited by 45
A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers
Lingfei, K., Pingzhang, Y., Zhengguo, L., Jianhua, G., & Yao-wu, Z. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00115-3 · Cited by 45
Velasco, J. A., Feijoó, E., Avila, M. A., & Notario, V. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199803)21:3<177::aid-mc5>3.0.co;2-j · Cited by 4
Wang, T.-J., Huang, M.-S., Hong, C.-Y., Tse, V., Silverberg, G. D., & Hsiao, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5565 · Cited by 44
Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
Chi, S. G., White, R. D., Muenzer, J. T., & Gumerlock, P. H. (1997) · PubMed · Cited by 53
Akama, Y., Yasui, W., Kuniyasu, H., Yokozaki, H., Akagi, M., Tahara, H., Ishikawa, T., & 田原, 榮. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb02106.x · Cited by 46
Cheng, L., Rossi, F., Fang, W., Mori, T., & Cobrinik, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005707200 · Cited by 43
Hirose, T., Kawabuchi, M., Tamaru, T., Okumura, N., Nagai, K., & Okada, M. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01218.x · Cited by 46
Simmons, A. D., Nguyen, M., & Pintus, E. (2020) · BMC Cancer · doi:10.1186/s12885-020-6657-2 · Cited by 42
Kannengiesser, C., Brookes, S., del Arroyo, A. G., Pham, D., Bombled, J., Barrois, M., Mauffret, O., Avril M, M.-F., Chompret, A., Lenoir, G. M., et al. (2009) · Human Mutation · doi:10.1002/humu.20845 · Cited by 41
Yu, B. D., Becker-Hapak, M., Snyder, E. L., Vooijs, M., Denicourt, C., & Dowdy, S. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2431391100 · Cited by 42
Diccianni, M. B., Batova, A., Yu, J., Vu, T., Pullen, J., Amylon, M. D., Pollock, B. H., & Yu, A. L.-T. (1997) · Leukemia Research · doi:10.1016/s0145-2126(97)00007-6 · Cited by 44
G1 Cyclins are Involved in the Mechanism of Cardiac Myocyte Hypertrophy Induced by Angiotensin II
Nozato, T., Ito, H., Tamamori, M., Adachi, S., Abe, S., Marumo, F., & Hiroe, M. (2000) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.64.595 · Cited by 47
Horn, L., Richter, C. E., Einenkel, J., Tannapfel, A., Liebert, U.-G., & Leo, C. (2006) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2005.09.001 · Cited by 41
Alterations of p16-pRb Pathway and Chromosome Locus 9p21–22 in Sporadic Invasive Breast Carcinomas
Gorgoulis, V. G., Koutroumbi, E., Kotsinas, A., Zacharatos, P., Markopoulos, C. J., Giannikos, L., Kyriakou, V., Voulgaris, Z., Gogas, I., & Kittas, C. N. (1998) · Molecular Medicine · doi:10.1007/bf03401773 · Cited by 45
Costanzi-Strauss, E., Strauss, B. E., Naviaux, R. K., & Haas, M. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3810 · Cited by 44
p16INK4A as a human tumor suppressor
Shapiro, G. I., & Rollins, B. J. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00011-4 · Cited by 44
Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis
Motwani, J., & Eccles, M. R. (2021) · Genes · doi:10.3390/genes12101543 · Cited by 50
Al‐Khalaf, H. H., Mohideen, P., Nallar, S. C., Kalvakolanu, D. V., & Aboussekhra, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512640 · Cited by 45
Bandara, L. R., Girling, R., & Thangue, N. B. L. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-896 · Cited by 45
Active RB Elicits Late G1/S Inhibition
Angus, S. P., Fribourg, A. F., Markey, M. P., Williams, S., Horn, H. F., DeGregori, J. V., Kowalik, T. F., Fukasawa, K., & Knudsen, E. S. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5510 · Cited by 45
Predicting functional significance of cancer-associated p16INK4a mutations in CDKN2A
McKenzie, H. A., Fung, C., Becker, T. M., Irvine, M., Mann, G. J., Kefford, R. F., & Rizos, H. (2010) · Human Mutation · doi:10.1002/humu.21245 · Cited by 39
Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia
Bamberger, A., Riethdorf, L., Milde‐Langosch, K., Bamberger, C. M., Thuneke, I., Erdmann, I., Schulte, H. M., & Löning, T. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050361 · Cited by 40
Melanoma Genetics: An Update on Risk-Associated Genes
Udayakumar, D., & Tsao, H. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.03.011 · Cited by 44
Kr̨ecicki, T., Śmigiel, R. S., Frączek, M., Kowalczyk, M., & Sasiadek, M. M. (2004) · The Journal of Laryngology & Otology · doi:10.1258/0022215042244769 · Cited by 36
Parkinson, E. K., Newbold, R. F., & Keith, W. N. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00063-4 · Cited by 39
Peeper, D. S., & Bernards, R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00319-0 · Cited by 36
Spillare, E. A., Okamoto, A., Hagiwara, K., Demetrick, D. J., Serrano, M., Beach, D., & Harris, C. C. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199605)16:1<1::aid-mc1>3.0.co;2-n · Cited by 36
D’Amico, M., Wu, K., Fu, M., Rao, M., Albanese, C., Russell, R. G., Lian, H., Bregman, D. B., White, M. A., & Pestell, R. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2519 · Cited by 45
Homozygous deletions of the CDKN2/p16 gene in dural hemangiopericytomas
Ono, Y., Ueki, K., Joseph, J. T., & Louis, D. N. (1996) · Acta Neuropathologica · doi:10.1007/s004010050419 · Cited by 38
The regulation of cyclin-dependent kinase inhibitors (CKIs)
Peter, M. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_8 · Cited by 42
Targeting hyperproliferative disorders with cyclin dependent kinase inhibitors
Rosania, G. R., & Chang, Y. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.2.215 · Cited by 43
Classifying variants of CDKN2A using computational and laboratory studies
Miller, P. J., Duraisamy, S., Newell, J. A., Chan, P. A., Tie, M. M., Rogers, A. E., Ankuda, C. K., von Walstrom, G. M., Bond, J. P., & Greenblatt, M. S. (2011) · Human Mutation · doi:10.1002/humu.21504 · Cited by 41
Kamoshida, S., Matsuoka, H., Ishikawa, T., Maeda, K., Shimomura, R., Inada, K.-I., & Tsutsumi, Y. (2004) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyh113 · Cited by 37
Nozato, T., Ito, H., Watanabe, M., Ono, Y., Adachi, S., Tanaka, H., Hiroe, M., Sunamori, M., & Marum, F. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1412 · Cited by 39
Metadata
- Authors
- Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E.
- Affiliations
- Massachusetts General Hospital (US)
- ORCID
- Koh, James
- Venue
- Nature
- Published
- 1995-06
- Volume
- 375
- Issue
- 6531
- Pages
- 506-510
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2035882662
- Cited by
- 516
- References
- 26
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 8 · 2022: 2 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 10 · 2016: 11 · 2015: 9 · 2014: 9 · 2013: 14 · 2012: 8
- FWCI
- 25.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p16, tumour suppressor, cyclin-dependent kinase inhibitors, G1 cell cycle arrest, retinoblastoma protein, familial melanoma, tumor progression, cell cycle regulation
- MeSH terms
- Alleles, Animals, Carrier Proteins, Cell Line, Humans, Mutation, Recombinant Proteins, Transfection, Tumor Cells, Cultured, Genes, Tumor Suppressor, G1 Phase, 3T3 Cells, Cyclin-Dependent Kinase Inhibitor p16, Protein Kinase Inhibitors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.